- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Empagliflozin/Metformin XR, FDC
Total 326 results
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
AstraZenecaCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
AstraZenecaCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
AstraZenecaCompletedHealthy Subjects in Fasted and Fed StateBrazil
-
AstraZenecaCompletedBioequivalence | Fixed Dose Combination Tablets | Healthy Male and Female SubjectsUnited States
-
AstraZenecaRecruiting
-
Handok Inc.CompletedHealthy VolunteersKorea, Republic of
-
University of GuadalajaraRecruiting
-
Boehringer IngelheimCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited Kingdom
-
Shandong Suncadia Medicine Co., Ltd.Not yet recruiting
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil
-
Handok Inc.CompletedHealthy VolunteersKorea, Republic of
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Bristol-Myers SquibbCompletedType 2 Diabetes MellitusSouth Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
AstraZenecaWithdrawn
-
Janssen Research & Development, LLCCompleted
-
Novartis PharmaceuticalsTerminated
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
Janssen Research & Development, LLCCompleted
-
AstraZenecaBiocardCompletedDiabetes Mellitus, Type 2Russian Federation
-
University Medical Centre LjubljanaUnknownDiabetes Complications | Diabetes Mellitus, Type 1 | Vascular Stiffness | Hypoglycemic AgentsSlovenia
-
Janssen Research & Development, LLCCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedDiabetes Mellitus, Type 2Germany
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
The University of QueenslandRecruitingAutosomal Dominant Polycystic Kidney DiseaseAustralia
-
Janssen Research & Development, LLCCompleted
-
Dexa Medica GroupCompletedInsulin Resistance | Polycystic Ovary Syndrome (PCOS)Indonesia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Dexa Medica GroupCompletedPolycystic Ovary Syndrome (PCOS)Indonesia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United States, Mexico, Puerto Rico, Philippines, Russian Federation, Ukraine
-
Merck Sharp & Dohme LLCCompleted
-
Brigham and Women's HospitalUnknown
-
Janssen Research & Development, LLCCompleted
-
Woman'sAstraZenecaCompletedDapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women (DAPA-GDM)Diabetes Prevention in Women After GDM Who Are at High-riskUnited States
-
Woman'sNovo Nordisk A/SCompletedType 2 Diabetes Mellitus | Metabolic Syndrome | Impaired Glucose Tolerance | Gestational Diabetes Mellitus | Disorder of Glucose RegulationUnited States
-
Janssen Research & Development, LLCCompletedHealthy VolunteersUnited States
-
Genuine Research Center, EgyptHikma PharmaCompleted
-
NYU Langone HealthCompleted